Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026
Senti Biosciences announced that CEO Timothy Lu will present on their innovative Logic-Gated SENTI-202 cell therapy at the AACR Annual Meeting 2026, highlighting promising clinical trial results in relapsed/refractory acute myeloid leukemia and the potential of Logic Gates to improve cancer therapy precision and efficacy.